To compare the effects of oral tofacitinib plus oral puvasol with oral corticosteroids plus oral puvasol in vitiligo patients and also study the side effects of bothe drugs
Phase 4
- Conditions
- Health Condition 1: L80- Vitiligo
- Registration Number
- CTRI/2024/06/069125
- Lead Sponsor
- SUPRIYA BEHERA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Age more than 18 years
2. Body surface area less than 80%
3. Progressive disease( peak of incidence within 6 months )
Exclusion Criteria
1. Universal vitiligo
2. Pregnant and lactating women
3. Patients undergoing immunosuppressive therapy
4. Patients of leukoderma due to other causes
5. Patients having photosensitivity
6. Patients having malignancy or undergone radiotherapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method